Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: Arnie1, PharrmaBro
Search This Board: 
Last Post: 1/28/2022 7:48:43 PM - Followers: 327 - Board type: Free - Posts Today: 0

Cyrcadia Asia, Hong Konghttps://www.rouse.com/magazine/news/rouse-ventures-team-scores-win-for-breast-cancer-detection-wearable-cyrcadia/



Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

http://www.firstwarningsystems.com/ became Cyrcadia Health http://cyrcadiahealth.com/

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. http://www.lbti.com

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at http://www.cyrcadiahealth.com/

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine




Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website http://detectedmovie.com/
Detected Facebook https://www.facebook.com/detectedmovie
Detected Twitter https://twitter.com/detectedmovie

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics



iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.




Detected Movie Youtube channel

Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra

Detected: Behind the Scenes with Ironbound Films

Wearable & Social Breast Cancer Screening

Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#34808   We'll have to watch and see. GetSeriousOK 01/28/22 07:48:43 PM
#34807   O/S is irrelevant until we see Value of Dspetry 01/28/22 05:11:39 PM
#34806   What do you think that means for PPS Groveman1 01/28/22 04:12:15 PM
#34805   but did you see that O/S increase? scary. GetSeriousOK 01/28/22 04:05:56 PM
#34804   Oh, I'm sure plenty of people know about Dspetry 01/28/22 02:12:26 PM
#34803   GetSer, I'm just going by what StockRunners tweeeted Groveman1 01/28/22 02:10:30 PM
#34802   chart for KRFG is not good for a GetSeriousOK 01/28/22 02:00:35 PM
#34801   Just read on StockRunners Tweet site, Caren Currier Groveman1 01/28/22 01:35:56 PM
#34800   No, Acropolis is an entity that has more GetSeriousOK 01/28/22 01:24:47 PM
#34799   GetSer, Do you believe Caren Curriers' Health may Groveman1 01/28/22 12:55:28 PM
#34798   I ask because a friend of mine had GetSeriousOK 01/28/22 12:30:33 PM
#34797   GetS: No stents! Stent was experimental then! Strictly Arnie1 01/28/22 12:16:12 PM
#34796   Congratulations! Impressive. Did you ever need the stents replaced? GetSeriousOK 01/28/22 11:39:57 AM
#34795   GetS: IMO, the Surgery was done properly on Arnie1 01/28/22 11:35:02 AM
#34794   Yes and it's wrong. Whoever wrote that article GetSeriousOK 01/28/22 09:14:29 AM
#34793   GetSer, The Article that Luckyyou sent everyone spelled Groveman1 01/28/22 08:46:14 AM
#34792   STENTS not "stints." GetSeriousOK 01/28/22 08:41:29 AM
#34791   Great Find Lucky, Maybe that explains some of Groveman1 01/28/22 08:06:21 AM
#34790   Wow…https://finance.yahoo.com/news/one-world-universe-donate-proceeds-160800742. Luckyyu 01/28/22 12:33:38 AM
#34789   Thanks GetSer, I wrote Legal accidently, Didn't notice Groveman1 01/25/22 12:17:27 PM
#34788   LLC stands for "Limited Liability Company." GetSeriousOK 01/25/22 08:53:22 AM
#34787   Remember Acropolis is an LLC (Limited Legal Company), Groveman1 01/25/22 08:24:19 AM
#34786   15’s getting hit hmm JMoneyHoops 01/24/22 05:21:18 PM
#34785   G: This will be in time for Valentine!! Arnie1 01/22/22 01:53:29 PM
#34784   I believe last Tweet from Acropolis on LLBO Groveman1 01/22/22 12:38:32 PM
#34783   Thanks Get Ser, It's just frustrating for everyone Groveman1 01/21/22 08:07:32 AM
#34781   LLBO was a scam when Holmes ran it, GetSeriousOK 01/20/22 04:53:11 PM
#34780   LLBO never reported to the SEC so of GetSeriousOK 01/20/22 04:50:51 PM
#34778   what is a "defunk warning?" LLBO is selling GetSeriousOK 01/20/22 01:01:08 PM
#34777   LLBO is not delisted and it never will GetSeriousOK 01/20/22 12:55:39 PM
#34776   Oct.4,2021 Audit began for LLBO. That's (3 1/2) Groveman1 01/20/22 12:46:21 PM
#34775   The judge doesn’t care. We are all awaiting the Dspetry 01/20/22 12:00:11 PM
#34773   https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154207031 PharrmaBro 01/20/22 11:29:07 AM
#34772   Go LLBO ! PharrmaBro 01/20/22 11:27:14 AM
#34771   Mentioned they aren’t current with sec PharrmaBro 01/20/22 11:26:55 AM
#34770   Mentioned LLBO was big scam PharrmaBro 01/20/22 11:26:37 AM
#34769   Mentioned LLBO will be delisted PharrmaBro 01/20/22 11:26:21 AM
#34768   You mentioned Acropolis years ago? Nice! GetSeriousOK 01/20/22 11:17:11 AM
#34767   Amazing how everything you guys are concerned about PharrmaBro 01/20/22 11:10:07 AM
#34766   "Tossing in the Towel" isn't something the judge GetSeriousOK 01/20/22 10:32:10 AM
#34765   Thanks GetSer, I still believe Investors were misled,(WHERE Groveman1 01/20/22 08:14:55 AM
#34764   We were saying that two months ago. GetSeriousOK 01/19/22 07:00:29 PM
#34763   When Holmes said in 2019 that the 12 GetSeriousOK 01/19/22 05:56:38 PM
#34762   This should be audited by now filings are imminent JMoneyHoops 01/19/22 04:15:48 PM
#34761   Just saying, Judge made his decision for Custodianship Groveman1 01/19/22 12:56:20 PM
#34760   Acropolis would never "toss LLBO aside." It wouldn't GetSeriousOK 01/19/22 12:49:44 PM
#34759   Just seems with Holmes claiming 35% ownership in Groveman1 01/19/22 12:33:21 PM
#34758   GetS: Thank you for your thoughts! Really appreciate it!! Arnie1 01/19/22 11:09:03 AM
#34757   Acropolis doesn't care about the PPS -- they GetSeriousOK 01/19/22 10:01:31 AM
#34756   GetSer, Why is Acropolis so secretive. There is Groveman1 01/19/22 09:01:23 AM
Consent Preferences